Testing for COVID-19: Increasing testing supply

On this page

What Canada is doing

Testing and screening, along with local public health measures and vaccination, are important tools to limit the spread of COVID-19 and its variants.

Canada is:

Increasing testing options

Health Canada reviews testing devices to assess safety, effectiveness and quality before authorizing for sale in Canada. For us to authorize a test, the manufacturer must submit an application for review.

Health Canada has authorized over 100 different COVID-19 tests. We also continue to fast-track the review of COVID-19 tests, including new testing options.

We are currently prioritizing the review of tests that are:

Health Canada is also prioritizing the review of novel technology, such as breathalyzers, for use in Canada. We are working with manufacturers to ensure these novel technologies are safe and effective.

In all cases, manufacturers must prove that the test is safe and effective by the intended user before we will authorize it. For example, for self-testing kits, the manufacturer must prove that a person can use their test safely and effectively without being supervised by a health care professional.

Securing and distributing rapid tests

On behalf of the federal government, Public Services and Procurement Canada purchased hundreds of millions of COVID-19 rapid tests to distribute across the country. This purchase ensures that the Canada can increase testing capacity with authorized, proven and effective technologies. Find out about our rapid test agreements and the types of COVID-19 rapid tests purchased.

There is currently a delay in reporting the deployment of COVID-19 rapid tests due to the time it takes for tests to be:

The tables on this page show the number of COVID-19 rapid tests that have been:

These numbers are updated regularly.

Shipment and distribution of COVID-19 rapid tests in Canada:

Shipments in Canada by company/product
Shipment of COVID-19 rapid tests in Canada
CompanyFootnote * name Product name Tests received from suppliers Tests shipped to provinces/territories
Abbott Rapid Diagnostics ULC Panbio COVID-19 Ag Rapid Test 132,306,400 125,209,586
Abbott Rapid Diagnostics ULC ID Now Covid-19 7,023,024 5,777,000
Artron Laboratories Inc ARTRON COVID-19 ANTIGEN TEST 33,702,801 33,702,426
Becton Dickinson Canada Inc.
BD Veritor™ System for Rapid Detection of SARS-CoV-2 12,208,770 10,742,910
Btnx Inc Rapid Response COVID-19 Antigen Rapid test Device 389,759,200 353,769,901
CanAm Scientific Inc. SARS-COV-2 Rapid Antigen Nasal SD Biosensor 2,419,110 426,300
Lucira Health Inc. Lucira CHECK✓IT COVID-19 Test Kit 212,410 75,736
Maverin Inc. ACON Flowflex SARS-CoV-2 Antigen Rapid Test 20,500,000 1,295,400
Precision Biomonitoring Inc. (Canada) Triplelock SARS-CoV-2 Tests 3,506,000 3,495,200
Quidel Canada ULC Sofia SARS Antigen FIA 850,000 73,200
Quidel Canada ULC QuickVue At-Home OTC COVID Test 16,905,775 6,220,575
Roche Diagnostics SD Biosensor SARS-CoV-2 Rapid Antigen Self Test NASAL 11,229,350 11,135,525
Switch Health Holdings Inc. SD Biosensor, Inc Standard Q Covid 19 AG Nasal Test 92,759,725 48,403,425
Trimedic Therapeutics COVID-19 Antigen Rapid Test / Assuretech 7,857,080 7,857,080
Total 731,239,645 608,184,264


Footnote *

"Company" may refer to the manufacturer of the device or a third-party supplier.

Return to footnote * referrer

Shipments to and distribution by provinces and territories
Shipment of COVID-19 rapid tests to and distribution by provinces/territories
Province/territory Tests shipped to province/territory Tests distributed by province/territory
Alberta 77,649,300 40,143,478
British Columbia 74,296,801 29,351,941
Manitoba 24,575,534 14,636,068
New Brunswick 17,326,280 15,225,182
Newfoundland and Labrador 9,008,222 4,423,824
Nova Scotia 21,625,177 13,433,658
Northwest Territories 774,736 369,116
Nunavut 710,229 214,702
Ontario 216,107,325 172,186,793
Prince Edward Island 3,258,571 1,942,909
Quebec 131,993,248 110,626,018
Saskatchewan 30,126,845 23,691,283
Yukon 731,996 616,112
Total 608,184,264 426,861,084
Federal allocation

As of September 13, 2022

Federal distribution of COVID-19 rapid tests to workplaces, community groups and non-profit organizations
Recipient Tests shipped
Private-sector workplacesFootnote * 13,557,720
Federal departments/ agencies, RCMP, Canadian Armed Forces (CAF), workplaces 6,208,742
Community groups and non-profit organizationsFootnote ** 7,927,791
Total 27,694,253


Footnote *

Includes tests shipped directly from Health Canada to medium-large organizations and to participating pharmacy distributors for re-distribution to Small-Medium Enterprises

Return to footnote * referrer

Footnote **

Includes tests shipped to Canadian Red Cross and northern grocers for re-distribution to registered charities or non-profit organizations (for workplaces or individual distribution), gateway airports, and Northern, Remote and Isolated Communities, etc.

Return to footnote ** referrer

Supporting testing capacity across Canada

The federal government has provided $4.28 billion to the provinces and territories to help them:

Canada is also providing funding and support to improve and modernize data management. This will help all levels of government coordinate their efforts to contain the virus.

For more information, refer to:

Related links

Did you find what you were looking for?

What was wrong?

You will not receive a reply. Telephone numbers and email addresses will be removed.
Maximum 300 characters

Thank you for your feedback

Date modified: